Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany

• Main Authors: Felicitas Kühne (Author), Katharina Achtert (Author), Franziska Püschner (Author), Dominika Urbanski-Rini (Author), Juliane Schiller (Author), Ernestine Mahar (Author), Josephine Friedrich (Author), Mark Atwood (Author), Ralf Sprenger (Author), Jeffrey Vietri (Author), Christof von Eiff (Author), Christian Theilacker (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives Despite national recommendations for use ofpneumococcal vaccines, rates of community-acquired pneumonia (CAP) and invasivepneumococcal disease (IPD) remain high in Germany. New pneumococcal conjugatevaccines (PCVs) with expanded coverage have the potential to reduce thepneumococcal diseas...